<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cells</journal-id>
<journal-id journal-id-type="iso-abbrev">Cells</journal-id>
<journal-id journal-id-type="publisher-id">cells</journal-id>
<journal-title-group>
<journal-title>Cells</journal-title>
</journal-title-group>
<issn pub-type="epub">2073-4409</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31590334</article-id>
<article-id pub-id-type="pmc">6829503</article-id>
<article-id pub-id-type="doi">10.3390/cells8101199</article-id>
<article-id pub-id-type="publisher-id">cells-08-01199</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Defective Excitatory/Inhibitory Synaptic Balance and Increased Neuron Apoptosis in a Zebrafish Model of Dravet Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2845-1156</contrib-id>
<name>
<surname>Brenet</surname>
<given-names>Alexandre</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hassan-Abdi</surname>
<given-names>Rahma</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8255-0898</contrib-id>
<name>
<surname>Somkhit</surname>
<given-names>Julie</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yanicostas</surname>
<given-names>Constantin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7734-9401</contrib-id>
<name>
<surname>Soussi-Yanicostas</surname>
<given-names>Nadia</given-names>
</name>
<xref ref-type="corresp" rid="c1-cells-08-01199">*</xref>
</contrib>
</contrib-group>
<aff id="af1-cells-08-01199">Université de Paris, NeuroDiderot, Inserm, F-75019 Paris, France</aff>
<author-notes>
<corresp id="c1-cells-08-01199"><label>*</label>Correspondence: <email>nadia.soussi@inserm.fr</email>; Tel.: +00-33140-03-1931</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>10</month>
<year>2019</year>
</pub-date>
<volume>8</volume>
<issue>10</issue>
<elocation-id>1199</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Dravet syndrome is a type of severe childhood epilepsy that responds poorly to current anti-epileptic drugs. In recent years, zebrafish disease models with Scn1Lab sodium channel deficiency have been generated to seek novel anti-epileptic drug candidates, some of which are currently undergoing clinical trials. However, the spectrum of neuronal deficits observed following Scn1Lab depletion in zebrafish larvae has not yet been fully explored. To fill this gap and gain a better understanding of the mechanisms underlying neuron hyperexcitation in Scn1Lab-depleted larvae, we analyzed neuron activity in vivo using combined local field potential recording and transient calcium uptake imaging, studied the distribution of excitatory and inhibitory synapses and neurons as well as investigated neuron apoptosis. We found that Scn1Lab-depleted larvae displayed recurrent epileptiform seizure events, associating massive synchronous calcium uptakes and ictal-like local field potential bursts. Scn1Lab-depletion also caused a dramatic shift in the neuronal and synaptic balance toward excitation and increased neuronal death. Our results thus provide in vivo evidence suggesting that Scn1Lab loss of function causes neuron hyperexcitation as the result of disturbed synaptic balance and increased neuronal apoptosis. </p>
</abstract>
<kwd-group>
<kwd>Dravet syndrome</kwd>
<kwd>Calcium imaging</kwd>
<kwd>Local field potential</kwd>
<kwd>Excitatory/inhibitory balance</kwd>
<kwd>Apoptosis</kwd>
<kwd>In vivo imaging</kwd>
<kwd>Zebrafish</kwd>
<kwd>
<italic>scn1Lab</italic>
</kwd>
<kwd>Morpholino scn1Lab<sup>AUG</sup></kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-cells-08-01199" sec-type="intro">
<title>1. Introduction</title>
<p>Dravet syndrome (DS) is a type of severe drug-resistant childhood epilepsy. It is associated with several comorbidities, including intellectual disability, irreversible psychomotor deficits, behavioral disorders, and high mortality at around 10 years of age [<xref ref-type="bibr" rid="B1-cells-08-01199">1</xref>,<xref ref-type="bibr" rid="B2-cells-08-01199">2</xref>]. DS is a genetic disease, caused in 80% of cases by de novo loss of function mutations in the <italic>SCN1A</italic> gene encoding the alpha-1 subunit of the main voltage-dependent sodium channel in inhibitory interneurons [<xref ref-type="bibr" rid="B3-cells-08-01199">3</xref>], whose synapses mainly release GABA, a neurotransmitter that inhibits excitation of post-synaptic neurons [<xref ref-type="bibr" rid="B4-cells-08-01199">4</xref>].</p>
<p>Among animal models that have been developed in recent years, the zebrafish has proved to be a versatile and powerful system for in vivo epilepsy research [<xref ref-type="bibr" rid="B5-cells-08-01199">5</xref>,<xref ref-type="bibr" rid="B6-cells-08-01199">6</xref>,<xref ref-type="bibr" rid="B7-cells-08-01199">7</xref>]. In particular, zebrafish larvae with loss of function of the <italic>scn1Lab</italic> gene, one of the two zebrafish orthologs of <italic>SCN1A</italic>, have already been used as animal models to find novel antiepileptic drug candidates, several of which are now undergoing clinical trials [<xref ref-type="bibr" rid="B8-cells-08-01199">8</xref>,<xref ref-type="bibr" rid="B9-cells-08-01199">9</xref>,<xref ref-type="bibr" rid="B10-cells-08-01199">10</xref>]. </p>
<p>However, while Scn1Lab-depleted larvae have been established as a bona fide epilepsy model [<xref ref-type="bibr" rid="B7-cells-08-01199">7</xref>,<xref ref-type="bibr" rid="B8-cells-08-01199">8</xref>,<xref ref-type="bibr" rid="B9-cells-08-01199">9</xref>,<xref ref-type="bibr" rid="B10-cells-08-01199">10</xref>,<xref ref-type="bibr" rid="B11-cells-08-01199">11</xref>,<xref ref-type="bibr" rid="B12-cells-08-01199">12</xref>,<xref ref-type="bibr" rid="B13-cells-08-01199">13</xref>,<xref ref-type="bibr" rid="B14-cells-08-01199">14</xref>,<xref ref-type="bibr" rid="B15-cells-08-01199">15</xref>], the spectrum of neuronal deficits induced by the loss of function of this sodium channel has not yet been fully explored. To fill this gap, we first combined transient calcium uptake imaging and local field potential recording to analyze neuron hyperactivity at whole brain levels in real time. In Scn1Lab-depleted larvae, we observed recurrent events associating massive synchronous calcium uptakes and ictal-like local field potential bursts characteristic of epileptiform seizures. Importantly, we also observed that these larvae displayed a marked deficit in the number of inhibitory synapses, together with a dramatic over-accumulation of excitatory ones, heavily disrupting the synaptic balance, which was correlated with a shift in the neuronal population toward excitatory neurons. Last, we observed that loss of function of this sodium channel caused increased neuronal apoptosis. Taken together, our findings are evidence that Scn1Lab-depletion causes epileptiform seizures as a result of brain development defects that include impaired synaptic balance and increased neuronal death. </p>
</sec>
<sec id="sec2-cells-08-01199">
<title>2. Materials and Methods</title>
<sec id="sec2dot1-cells-08-01199">
<title>2.1. Fish Maintenance and Transgenic Lines</title>
<p>Adult zebrafish were raised at 26.5 °C in standard aquaculture conditions with a 14 h light/10 h dark cycle. Embryos collected by natural spawning were raised in E3 medium complemented with 0.002% methylene blue and kept at 28.5 °C. 0.003% phenylthiourea (PTU; Sigma) was added at 1 day post-fertilization (dpf) to inhibit pigmentation. The mutant <italic>scn1Lab</italic> (didy<sup>S552</sup>) was a gift from Dr. Scott Baraban (University of California, San Francisco, USA), the HuC:GCaMP5G transgenic line was a gift from Dr. George Debrégeas (Laboratoire Jean Perrin, Paris) and the Gad1b:GFP; Vglut2a:DsRed double transgenic line was a gift from Dr Germán Sumbre (IBENS, Paris).</p>
<p>All the animal experiments described in the present study were conducted at the French National Institute of Health and Medical Research (INSERM) UMR 1141 in Paris in accordance with European Union guidelines for the handling of laboratory animals (<uri xlink:href="http://ec.europa.eu/environment/chemicals/lab_animals/home_en.htm">http://ec.europa.eu/environment/chemicals/lab_animals/home_en.htm</uri>), and were approved by the Direction Départementale de la Protection des Populations de Paris and the French Animal Ethics Committee under reference No. 2012-15/676-0069.</p>
</sec>
<sec id="sec2dot2-cells-08-01199">
<title>2.2. Morpholino</title>
<p>Antisense morpholino-oligonucleotide (MO) (5′-CTGAGCAGCCATATTGACATCCTGC-3′), obtained from Gene Tools, was used to block the <italic>scn1Lab</italic> zebrafish mRNA translation One- to two-cell embryos were injected with 1 pmol MO scn1Lab<sup>AUG</sup>, 0.53 ng rhodamine B dextran and 0.1 mM KCl.</p>
</sec>
<sec id="sec2dot3-cells-08-01199">
<title>2.3. Locomotor Activity</title>
<p>Larvae locomotor activity (i.e., movement) was evaluated using the Zebrabox, an infrared automated recording and tracking device supported by ZebraLab software (Viewpoint, Lyon, France). Each 96-well plate containing 4 dpf control, morphant or mutant larvae in 200 µL E3 medium was placed in the Zebrabox recording chamber. In all locomotion recording protocols, animal color was set to dark and detection threshold to 15. After 45 min habituation in darkness, larvae were simultaneously tracked for 25 min. Larvae movement in each well was computed as the sum of all pixels for which intensity changed during the recording, and plotted as “acting units”.</p>
</sec>
<sec id="sec2dot4-cells-08-01199">
<title>2.4. Calcium Imaging</title>
<p>4 dpf zebrafish larvae were paralyzed using 300 µM pancuronium bromide (PB, Sigma) and immobilized dorsal-side down at the center of a recording chamber in 1.2% low-melting agarose covered with E3 medium containing 0.003% PTU and 300 µM PB. The chamber was then placed on an inverted a Leica SP8 laser scanning confocal microscope equipped with a 20x/multi-immersion 0.75 objective. Calcium uptake events were detected by recording the fluorescence of a 512 × 512-pixel image of a single focal plane at 2 Hz for 1 h. Fluorescence intensity of the optic tectum was measured using ImageJ software. Fluorescence variations (<italic>ΔF/F<sub>0</sub></italic>) were calculated by subtracting the mean fluorescence intensity of all frames and normalizing the mean fluorescence intensity of all frames. The fluorescence drift over time was corrected by subtracting the mean value of the lowest values (all values under the median) within a 20 s sliding window around the point. All fluorescence increases greater than 0.04 <italic>ΔF/F<sub>0</sub></italic> were considered as calcium events. Since the detection system may detect false events, all of them were manually checked.</p>
</sec>
<sec id="sec2dot5-cells-08-01199">
<title>2.5. Local Field Potential Recording</title>
<p>4 dpf zebrafish larvae were paralyzed using 300 µM PB and immobilized, ventral-side down, in 2% low-melting agarose covered with E3 medium containing 300 µM PB. A glass electrode (5 - 6 MΩ) filled with artificial cerebrospinal fluid composed of 10 mM HEPES, 134 mM NaCl, 2.9 mM KCl, 2.1 mM CaCl<sub>2</sub>, 1.2 mM MgCl<sub>2</sub>, 10 mM glucose; pH 7.8, was placed in the left neuropil of the optic tectum of the larva. The recordings were performed for 1 h in a current clamp mode at 10 µs sampling interval and with a 0.1 Hz high-pass filter, 1 kHz low-pass filter and digital gain at 10 (MultiClamp 700B amplifier, Digidata 1400 digitizer, both Molecular Devices). Results were analyzed with the Clampfit software (Molecular Devices, San José, CA, USA). Events were defined as every downward membrane potential variation under -0.3 mV amplitude and lasting more than 100 ms. </p>
</sec>
<sec id="sec2dot6-cells-08-01199">
<title>2.6. Synapse Immunostaining</title>
<p>4 dpf control and morphant larvae were fixed with 4% formaldehyde for 1 h 30 min at room temperature and stored at 4 °C in PBS containing 0.02% sodium azide. Fixed larvae were transferred to 15% sucrose at 4 °C overnight and then embedded in 7.5% gelatin/15% sucrose, flash frozen in isopentane at -45 °C and stored at -80 °C. When needed, frozen embedded larvae were cut into 20 µm thick sections using a cryostat, mounted on Superfrost slides and stored at -20 °C until immunostaining. For gephyrin, larvae were not fixed, but transferred in 15% sucrose for 1 h at room temperature, anesthetized with 0.01% tricaine and embedded in 7.5% gelatin/15% sucrose. 20-µm-thick sections were post-fixed for 10 min with 4% formaldehyde and treated with 0.25% trypsin diluted in PBS for 2 min. Immunostaining was performed as follows. Sections were washed three times with PBS, blocked and permeabilized with 0.2% gelatin/0.25% Triton diluted in PBS. Rabbit antibody anti-PSD-95 (Abcam, Ab18258, 1:200), an excitatory post-synaptic protein, or rabbit antibody anti-gephyrin (Abcam, Ab185993, 1:100), an inhibitory post-synaptic protein, were added onto the sections, which were incubated overnight at room temperature. Sections were washed several times and incubated with anti-rabbit IgG Alexa 488 conjugated antibody (Molecular Probes, A-21206, 1:500), in the dark at room temperature. After 1 h incubation, sections were washed and stained in the dark for 10 min with 0.3% DAPI. After a last wash, sections were mounted in Fluoromount medium and conserved at 4 °C in the dark. Sections were imaged using a Leica SP8 laser scanning confocal microscope equipped with a 40x/oil 1.3 objective. Optic tectum and telencephalon regions were captured at full resolution, 0.063 × 0.063 × 0.4 µm voxel size. Images were deconvoluted using AutoQuant (Media Cybernetics, Rockville, MD, USA) software and processed using ImageJ software. PSD-95 and gephyrin puncta were quantified using a semi-automated macro (Zsolt Csaba; Inserm UMR1141), which applied a threshold to segment the image and select only the puncta ranging between 0.018 µm² and 3.14 µm². The total number of PSD-95 or gephyrin puncta was finally divided by the surface area of interest to obtain the density of PSD-95 and gephyrin signal in the optic tectum. All manual cell counts were performed blind.</p>
</sec>
<sec id="sec2dot7-cells-08-01199">
<title>2.7. Identification and Counting of Inhibitory and Excitatory Neurons</title>
<p>3, 4 and 5 dpf larvae were anesthetized using 0.01% tricaine and embedded in 1.2% low-melting agarose, ventral-side down, in a recording chamber covered with E3 medium containing 0.003% PTU and 0.01% tricaine. The chamber was then placed under a Zeiss LSM 880 laser scanning confocal microscope equipped with a WPApo 20x/1.0 objective. 52 slices spanning approximately 100 µm were captured and processed using AutoQuant 3.1X (Media Cybernetics, Rockville, MD, USA). Gad1b and Vglut2a positive neurons in the optic tectum were counted using Imaris MeasurementPro8.4.2 (Bitplane, Zurich, Switzerland). Briefly, neurons were approximated as 7-µm-diameter spheres and sorted by their fluorescence intensity.</p>
</sec>
<sec id="sec2dot8-cells-08-01199">
<title>2.8. Neuronal Death</title>
<p>Neuronal death was detected in living zebrafish brains using acridine orange (AO), which binds to free nucleic acid. 4 dpf control and <italic>scn1Lab</italic> larvae were incubated for 20 min with 10 µM AO (VectaCell) in E3 medium. Larvae were washed several times, paralyzed with 300 µM PB and embedded in 1.1% low-melting agarose in the center of a 35 mm glass-bottom dish, covered with E3 medium containing 0.003% PTU and 300 µM PB. 100 µm brain stacks were acquired using a Leica SP8 laser confocal scanning microscope equipped with a 20x/multi-immersion 0.75 objective. In addition, 4 dpf control and morphant brains were dissected, fixed with 4% formaldehyde and stained with activated caspase-3 antibody. The brains were first washed with 0.1% triton in PBS, then permeabilized and blocked with 5% goat serum/1% Triton in PBS. Rabbit polyclonal antibody to activated caspase-3 (Abcam, Ab44976, 1:500) was added, which was incubated overnight at room temperature. Brains were washed several times and incubated with an anti-rabbit IgG Alexa 488 conjugated antibody (Molecular Probes, A-21206 1:500), for 1 h at room temperature in the dark. Brains were finally washed, embedded in 1.1% agarose in the center of a 35 mm glass-bottom dish and imaged using a Leica SP8 laser scanning confocal microscope equipped with a 20x/multi-immersion 0.75 objective. All images were processed using AutoQuant 3.1X (Media Cybernetics, Rockville, MD, USA) and ImageJ software.</p>
</sec>
<sec id="sec2dot9-cells-08-01199">
<title>2.9. Colocalization of Activated Caspase-3 Labeling with Inhibitory or Excitatory Neurons</title>
<p>4 dpf Tg[Gad1:GFP; Vglut2a:DsRed] larval brains were stained using activated caspase-3 antibody followed by anti-rabbit IgG Cy5 conjugated antibody (Molecular Probes, A-10523,1:300) and imaged as previously described. Images were processed using AutoQuant 3.1X (Media Cybernetics, Rockville, MD, USA). Colocalization of activated caspase-3 signals with Gad1b or Vglut2a positive neurons was assessed manually using ImageJ software.</p>
</sec>
<sec id="sec2dot10-cells-08-01199">
<title>2.10. Z-VAD Treatment</title>
<p>3 dpf control and <italic>scn1Lab</italic> larvae were incubated for 24 h with either vehicle or 300 µM Z-VAD-fmk (Sigma), in E3 medium containing 1% dimethyl sulfoxide (DMSO). Dead cells were then labeled using AO and imaged as previously described.</p>
</sec>
<sec id="sec2dot11-cells-08-01199">
<title>2.11. Statistics</title>
<p>Data were plotted and analyzed using GraphPad Prism 5. Data were checked for normality using the d’Agostino and Pearson omnibus normality test with alpha set at 0.05. Data that did not follow a normal distribution were compared with a Mann-Whitney test. Data that followed a normal distribution were analyzed with Student’s two-tailed unpaired <italic>t</italic>-test with or without Welch’s correction depending on the variance difference of each sample. Graphs show the mean and the SEM.</p>
</sec>
</sec>
<sec id="sec3-cells-08-01199" sec-type="results">
<title>3. Results</title>
<sec id="sec3dot1-cells-08-01199">
<title>3.1. Calcium Imaging Combined with LFP Recordings as Tools to Analyze Neuronal Activity in Vivo in Scn1Lab-Depleted Zebrafish Larvae</title>
<p>As previously described, zebrafish embryos injected with 1 pmol <italic>scn1Lab</italic><sup>AUG</sup> morpholino-oligonucleotide, hereafter referred to as <italic>scn1Lab</italic> morphants, and <italic>scn1Lab<sup>552/s552</sup></italic> mutants displayed several highly penetrant phenotypes, including black appearance resulting from defective pigment aggregation, failure to inflate their swim bladder, and, from 4 dpf onward, recurrent spontaneous epileptiform seizures, reflected by a markedly increased swimming activity of the larvae [<xref ref-type="bibr" rid="B8-cells-08-01199">8</xref>], [<xref ref-type="bibr" rid="B10-cells-08-01199">10</xref>], (<xref ref-type="app" rid="app1-cells-08-01199">Figure S1</xref>). Importantly, since phenotypes observed in <italic>scn1Lab</italic> morphants (<italic>N</italic> = 904), and particularly seizure number and intensity, were the same as those seen in <italic>scn1Lab<sup>s552/s552</sup></italic> mutants (<italic>N</italic> = 192), we decided to use the former to further characterize the neuronal phenotypes associated with loss of Scn1Lab function.</p>
<p>First, to confirm that the increased swimming activity observed in 4 dpf <italic>scn1Lab</italic> morphants did correspond to bona fide epileptic seizures caused by the synchronous hyperexcitation of large neuron populations, we generated zebrafish <italic>scn1Lab</italic> morphants that also carried the Tg[HuC:GCaMP5G] transgene encoding a calcium-dependent fluorescent protein expressed under the control of the pan-neuronal HuC promoter [<xref ref-type="bibr" rid="B16-cells-08-01199">16</xref>]. To record transient calcium uptakes associated with neuron hyperexcitation during epileptiform seizures, we imaged the optic tectum of pancuronium-paralyzed and agarose-immobilized 4 dpf larvae and simultaneously recorded forebrain local field potentials (LFPs) (<xref ref-type="fig" rid="cells-08-01199-f001">Figure 1</xref>A). Results show that scn1Lab<sup>AUG</sup> morphants displayed recurrent spontaneous transient calcium uptake events, events with <italic>ΔF/F<sub>0</sub></italic> &gt; 0.04, (<xref ref-type="fig" rid="cells-08-01199-f001">Figure 1</xref>E, F; <italic>p</italic> &lt; 0.001) that also precisely corresponded to multi-spike ictal-like discharges (correlation coefficient <italic>R<sup>2</sup></italic> = 0.772) (<xref ref-type="fig" rid="cells-08-01199-f001">Figure 1</xref>G,H), which were never seen in either non-injected larvae or control morphants (<xref ref-type="fig" rid="cells-08-01199-f001">Figure 1</xref>D) (<xref ref-type="app" rid="app1-cells-08-01199">Figure S2</xref>). Thus, in good agreement with previous results [<xref ref-type="bibr" rid="B8-cells-08-01199">8</xref>,<xref ref-type="bibr" rid="B10-cells-08-01199">10</xref>], 4 dpf Scn1Lab-depleted zebrafish larvae displayed epileptiform seizures, which could be detected in vivo by both calcium imaging techniques and LFP recordings. </p>
</sec>
<sec id="sec3dot2-cells-08-01199">
<title>3.2. Inhibitory/Excitatory Synaptic Balance is Disrupted in Scn1Lab-Depleted Larvae</title>
<p>Harmonious functioning of neuron networks relies on a finely tuned balance between excitatory and inhibitory inputs [<xref ref-type="bibr" rid="B17-cells-08-01199">17</xref>]. Synapses, which are essential components of this balance, comprise both excitatory and inhibitory subunits that release glutamate and GABA, respectively [<xref ref-type="bibr" rid="B18-cells-08-01199">18</xref>]. This balance is impaired in neurological disorders such as epilepsy in which large populations of neurons display synchronous hyperexcitation [<xref ref-type="bibr" rid="B19-cells-08-01199">19</xref>,<xref ref-type="bibr" rid="B20-cells-08-01199">20</xref>]. We recently showed that zebrafish <italic>gabra1<sup>-/-</sup></italic> and <italic>depdc5<sup>-/-</sup></italic> epileptic mutants displayed markedly fewer inhibitory synapses compared to age-matched control larvae, showing that these two mutants display brain development defects [<xref ref-type="bibr" rid="B21-cells-08-01199">21</xref>,<xref ref-type="bibr" rid="B22-cells-08-01199">22</xref>]. To determine whether Scn1Lab deficiency also induced unbalanced excitatory/inhibitory post-synaptic outputs, we analyzed and compared, by immunocytochemistry, the distribution of the two post-synaptic populations on brain sections of 5 dpf control and Scn1Lab-depleted larvae, using anti-PSD-95 and anti-gephyrin antibodies, which label excitatory and inhibitory post-synaptic terminals, respectively [<xref ref-type="bibr" rid="B23-cells-08-01199">23</xref>]. Quantification of the two post-synaptic populations showed a marked increase in PSD-95 labeling (<xref ref-type="fig" rid="cells-08-01199-f002">Figure 2</xref>B,C; <italic>p</italic> &lt; 0.01) combined with a clear decrease of that of gephyrin (<xref ref-type="fig" rid="cells-08-01199-f001">Figure 1</xref>E,F; <italic>p</italic> &lt; 0.01), in scn1Lab<sup>AUG</sup> morphants, compared to controls (<xref ref-type="fig" rid="cells-08-01199-f002">Figure 2</xref>A,D). These data clearly show that depletion of Scn1Lab causes a marked disruption of the synaptic balance, which is shifted toward excitation (<xref ref-type="fig" rid="cells-08-01199-f002">Figure 2</xref>G; <italic>p</italic> &lt; 0.01).</p>
</sec>
<sec id="sec3dot3-cells-08-01199">
<title>3.3. Distribution of Excitatory and Inhibitory Neurons in scn1Lab Model</title>
<p>We next assessed whether the defective excitatory/inhibitory synaptic balance seen in Scn1Lab-depleted larvae could be related to an abnormal ratio of inhibitory and excitatory neurons. To test this hypothesis, we used the double transgenic line Tg[Gad1b:GFP; Vglut2a:DsRed] that labels inhibitory neurons with GFP and excitatory neurons with DsRed [<xref ref-type="bibr" rid="B24-cells-08-01199">24</xref>,<xref ref-type="bibr" rid="B25-cells-08-01199">25</xref>] as recipient line to generate scn1Lab<sup>AUG</sup> morphants (<xref ref-type="fig" rid="cells-08-01199-f003">Figure 3</xref>). First, live imaging combined with quantitative image analysis revealed that the total number of neurons is significantly decreased in scn1Lab<sup>AUG</sup> morphants at 3 dpf (<xref ref-type="fig" rid="cells-08-01199-f003">Figure 3</xref>D; <italic>p</italic> &lt; 0.05), 4 dpf (<xref ref-type="fig" rid="cells-08-01199-f003">Figure 3</xref>G; <italic>p</italic> &lt; 0.001) and 5 dpf (<xref ref-type="fig" rid="cells-08-01199-f003">Figure 3</xref>J; <italic>p</italic> &lt; 0.01) when compared to age-matched controls. Next, we quantified the number of inhibitory (GFP<sup>+</sup>) and excitatory (DsRed<sup>+</sup>) neurons at 3, 4 and 5 dpf in scn1Lab<sup>AUG</sup> morphants and controls. Our results show that at 3 dpf, the percentage of excitatory and inhibitory neurons was similar in Scn1Lab-depleted and control larvae (<xref ref-type="fig" rid="cells-08-01199-f003">Figure 3</xref>K). By contrast, the ratio of excitatory to inhibitory neurons was markedly increased at 4 dpf (<xref ref-type="fig" rid="cells-08-01199-f003">Figure 3</xref>L; <italic>p</italic> &lt; 0.001) and 5 dpf (<xref ref-type="fig" rid="cells-08-01199-f003">Figure 3</xref>M; <italic>p</italic> &lt; 0.01). It is of note that the ratio of excitatory to inhibitory neurons did not change in control embryos between 3 and 5 dpf (<xref ref-type="fig" rid="cells-08-01199-f003">Figure 3</xref>K,L,M). </p>
</sec>
<sec id="sec3dot4-cells-08-01199">
<title>3.4. Increased Neuron Apoptosis in Scn1Lab-Depleted Larvae</title>
<p>A large body of data gained from the analysis of neuronal tissues from human epileptic patients and animal epilepsy models clearly indicates that both brief and prolonged seizures cause neuron death through activation of both apoptosis and autophagy signaling pathways [<xref ref-type="bibr" rid="B26-cells-08-01199">26</xref>,<xref ref-type="bibr" rid="B27-cells-08-01199">27</xref>,<xref ref-type="bibr" rid="B28-cells-08-01199">28</xref>]. We therefore investigated whether Scn1Lab depletion induced increased neuron apoptosis. We first used in vivo labeling with acridine orange. Results showed that the number of apoptotic cells was markedly increased in scn1Lab<sup>AUG</sup> morphants compared to control larvae (<xref ref-type="fig" rid="cells-08-01199-f004">Figure 4</xref>A,B,D; <italic>p</italic> &lt; 0.001). To confirm this result, we also visualized neuron apoptosis using immunocytochemistry and anti-activated caspase-3 antibody In good agreement with acridine orange staining, a significant increase in the number of activated caspase-3 positive cells were observed in the brain of Scn1Lab-depleted individuals compared to control larvae (<xref ref-type="fig" rid="cells-08-01199-f004">Figure 4</xref>E,F,G; <italic>p</italic> &lt; 0.001).</p>
<p>Because Scn1Lab-depleted larvae showed an increased number of apoptotic cells, we next investigated whether this apoptosis was caspase-dependent. To test this hypothesis, we used Z-VAD, a cell-permeable caspase inhibitor that reversibly binds to the catalytic site of caspase proteases and inhibits their activity [<xref ref-type="bibr" rid="B29-cells-08-01199">29</xref>]. We incubated 3 dpf Scn1Lab-depleted and control embryos for 24 h in E3 medium containing 300 µM Z-VAD and 1% DMSO [<xref ref-type="bibr" rid="B30-cells-08-01199">30</xref>,<xref ref-type="bibr" rid="B31-cells-08-01199">31</xref>,<xref ref-type="bibr" rid="B32-cells-08-01199">32</xref>]. As negative control, age-matched Scn1Lab-depleted and control larvae were incubated for 24 h in E3 medium containing 1% DMSO. Cell death was assessed using acridine orange staining combined with real-time confocal imaging. Our data show that following Z-VAD treatment, the number of acridine orange-positive cells increased in both control (<xref ref-type="fig" rid="cells-08-01199-f004">Figure 4</xref>A,H) and Scn1Lab-depleted larvae (<xref ref-type="fig" rid="cells-08-01199-f004">Figure 4</xref>B,I), suggesting that Z-VAD had no effect on cell apoptosis in <italic>scn1Lab</italic> model. </p>
<p>We next examined whether apoptotic death occurred in excitatory or inhibitory neurons. To do this, 4 dpf Tg[Gad1b:GFP; Vglut2a:DsRed], Scn1Lab-depleted and Tg[Gad1b:GFP; Vglut2a:DsRed] control larvae were fixed and analyzed by immunohistochemistry using anti-activated caspase-3 antibody. In both Scn1Lab-depleted (<xref ref-type="fig" rid="cells-08-01199-f004">Figure 4</xref>N<sub>1</sub>-<sub>4</sub>) and control (<xref ref-type="fig" rid="cells-08-01199-f004">Figure 4</xref>M<sub>1-4</sub>) Tg[Gad1b:GFP; Vglut2a:DsRed] larvae, we observed a greater number of excitatory neurons expressing activated caspase-3 than inhibitory ones. Quantification of the number of inhibitory and excitatory neurons colocalizing with activated caspase-3 expression, confirmed that neuronal death specifically affects excitatory neurons (<xref ref-type="fig" rid="cells-08-01199-f004">Figure 4</xref>L; Gad1b<sup>+</sup>-Act-Casp3<sup>+</sup>
<italic>vs</italic> Vglut2a<sup>+</sup>-Act-Casp3<sup>+</sup> controls: <italic>p</italic> &lt; 0.001; Gad1b<sup>+</sup>-Act-Casp3<sup>+</sup>
<italic>vs</italic> Vglut2a<sup>+</sup>-Act-Casp3<sup>+</sup>
<italic>scn1Lab</italic>: <italic>p</italic> &lt; 0.001). </p>
</sec>
</sec>
<sec id="sec4-cells-08-01199" sec-type="discussion">
<title>4. Discussion</title>
<p>Dravet syndrome (DS) is a catastrophic childhood epilepsy with multiple comorbidities, which include severe intellectual disability, impaired social development, persistent drug-resistant seizures and high risk of sudden unexpected death in epilepsy (SUDEP) [<xref ref-type="bibr" rid="B1-cells-08-01199">1</xref>,<xref ref-type="bibr" rid="B33-cells-08-01199">33</xref>]. In recent years, thanks to vertebrate genome conservation, full genome sequencing and readily available molecular tools and techniques, zebrafish has become a powerful and versatile animal model for studying genetic forms of epilepsy and also to screen for novel anti-epileptic drugs [<xref ref-type="bibr" rid="B8-cells-08-01199">8</xref>,<xref ref-type="bibr" rid="B10-cells-08-01199">10</xref>,<xref ref-type="bibr" rid="B22-cells-08-01199">22</xref>]. Among epilepsy mutants, zebrafish larvae with loss of function of the <italic>scn1Lab</italic> gene, one of the two zebrafish orthologs of <italic>SCN1A</italic>, was instrumental to identify drugs alleviating seizures in refractory epilepsy [<xref ref-type="bibr" rid="B8-cells-08-01199">8</xref>,<xref ref-type="bibr" rid="B10-cells-08-01199">10</xref>]. However, despite the large number of studies that have used Scn1Lab-depleted zebrafish mutants and morphants, the neuronal phenotypes induced by loss of function of this sodium channel encoding gene have not yet been fully investigated.</p>
<p>Using combined in vivo calcium imaging and local field potential (LFP) in the optic tectum of zebrafish models of DS, we observed a full correlation between calcium activity and neuronal activity, with both techniques consistently showing generalized ictal-like seizure events. Recent studies showed a correlation between calcium and local field potential activities using an acute PTZ seizure model in zebrafish [<xref ref-type="bibr" rid="B14-cells-08-01199">14</xref>]. To our knowledge, this is the first time that a correlation between calcium and electrical activities has been reported in a genetic model of epilepsy. This finding is important for research on epilepsy because it validates the use of calcium activity to monitor the dynamics of seizures at the scale of an entire vertebrate brain. In particular, calcium imaging provides a unique opportunity to follow the dynamics of seizures spatiotemporally, from the initiation site to propagation through the brain. </p>
<p>We focused on excitatory and inhibitory synapses by studying two important proteins that are markers of synaptic integrity, PSD-95 and gephyrin [<xref ref-type="bibr" rid="B23-cells-08-01199">23</xref>]. PSD-95, by its PDZ domains, serves as a scaffolding protein with a docking site for signaling proteins clustering around NMDA- and AMPA- type glutamate receptors, which are crucial for excitatory neurotransmission and synaptic plasticity [<xref ref-type="bibr" rid="B34-cells-08-01199">34</xref>]. Gephyrin is a core scaffolding protein, the postsynaptic component of inhibitory synapses, and it controls the formation and plasticity of inhibitory synapses through regulation of GABAA and glycine receptors [<xref ref-type="bibr" rid="B35-cells-08-01199">35</xref>]. In the present study, we demonstrated that levels of PSD-95 and gephyrin are modified in zebrafish models of DS. Indeed, by studying the distribution of excitatory and inhibitory neurons during development, we have shown that at 3 days of development, the ratio of excitatory to inhibitory neurons was comparable between Scn1Lab-depleted larvae and their sibling controls. Interestingly, from 4 days of development onward, we observed that the proportion of excitatory neurons increased when compared to that of inhibitory neurons in scn1Lab<sup>AUG</sup> morphants, while this ratio remained unchanged in control embryos. This specific neuronal death may therefore explain the severe gephyrin signal loss observed in the <italic>scn1Lab</italic> model. Moreover, the increase in excitatory neurons detected from 4 dpf onward probably corresponds to the beginning of the disease in Scn1Lab-depleted larvae. Interestingly, these data are in good agreement with our results obtained using LFP recording and calcium imaging, showing that the peak of seizures was observable at 4 and 5 dpf in Scn1Lab-depleted larvae [<xref ref-type="bibr" rid="B8-cells-08-01199">8</xref>].</p>
<p>Previous studies have shown that subtle changes in synaptic structure or composition, which alter synaptic plasticity and functional responses, most likely contribute to synaptic dysfunction [<xref ref-type="bibr" rid="B36-cells-08-01199">36</xref>]. Differences in key synaptic protein levels can provide information about the excitatory/inhibitory components of neurotransmission that might be disturbed or impaired during epileptogenesis [<xref ref-type="bibr" rid="B37-cells-08-01199">37</xref>]. It is known that the balance between excitatory and inhibitory synapses is impaired in patients with epilepsy [<xref ref-type="bibr" rid="B20-cells-08-01199">20</xref>]. These results are also in line with the observation of Stief et al. (2007) in another model of epilepsy in rats, that the balance between excitatory and inhibitory synapses is shifted toward an over-excited state [<xref ref-type="bibr" rid="B19-cells-08-01199">19</xref>].</p>
<p>Our results using a zebrafish model of DS show an increase in apoptotic cells as previously observed in models of epilepsy [<xref ref-type="bibr" rid="B26-cells-08-01199">26</xref>,<xref ref-type="bibr" rid="B27-cells-08-01199">27</xref>,<xref ref-type="bibr" rid="B28-cells-08-01199">28</xref>]. We have also shown that treatment of Scn1Lab-depleted larvae with Z-VAD fails to inhibit cell death, suggesting that Z-VAD has no effects on cell apoptosis in <italic>scn1Lab</italic> model. However, we cannot exclude the possibility that Z-VAD may cause cellular toxicity in <italic>scn1lab</italic> model thus masking its protective effect. Unexpectedly, colocalization analysis of inhibitory and excitatory neurons with activated caspase-3 staining at 4 dpf revealed that cell death preferentially targeted excitatory neurons. This could be explained by the fact that during seizures, excitatory neurons are hyper-excited and eventually die. In relation to this hypothesis, we sometimes observed during in vivo calcium imaging, using larvae from transgenic line Tg[HuC:GCaMP5G; <italic>scn1Lab</italic>], that some neurons became hyper-excited, as revealed by the over-expression of GFP labeling, and die (personal observations). </p>
<p>Our study emphasizes that the DS models are not only a powerful new tool for finding new antiepileptic drug candidates that could alleviate refractory seizures [<xref ref-type="bibr" rid="B8-cells-08-01199">8</xref>,<xref ref-type="bibr" rid="B9-cells-08-01199">9</xref>,<xref ref-type="bibr" rid="B10-cells-08-01199">10</xref>], but more importantly, they also display neurodevelopmental alterations characteristic of epileptic brains, such as the imbalance of excitatory/inhibitory synapses and apoptosis. Our data thus provide in vivo evidence for a developmental aspect of epileptogenesis that had been hypothesized [<xref ref-type="bibr" rid="B38-cells-08-01199">38</xref>,<xref ref-type="bibr" rid="B39-cells-08-01199">39</xref>], but not definitely proved. Our study shows that DS is a disease of the central nervous system, and it calls for a closer focus on neurodevelopmental defects leading to severe comorbidities in DS (speech deficiency, autism, etc.) and not just on managing refractory seizures with antiepileptic drugs. More research is needed to understand the exact neurodevelopmental abnormalities causing epilepsy and to correct them as early as possible, rather than only treating them symptomatically at later stages. In the same way, we showed previously that gabra1 loss of function (generalized epilepsy) induced developmental alterations, in particular for the establishment of GABAergic networks throughout the brain [<xref ref-type="bibr" rid="B22-cells-08-01199">22</xref>].</p>
<p>The findings reported here shed light on the neurobiological changes that occur in the early stages of DS, and are a promising start in understanding the neurodevelopmental origins of DS and finding potential treatments to restore normal brain development at earlier stages of the disease.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We also thank Christiane Romain (Inserm UMR 1141), Olivier Bar (Inserm UMR 1141), and Solène Renault (Inserm UMR 1141) for their technical assistance.</p>
</ack>
<app-group>
<app id="app1-cells-08-01199">
<title>Supplementary Materials</title>
<p>The following are available online at <uri xlink:href="https://www.mdpi.com/2073-4409/8/10/1199/s1">https://www.mdpi.com/2073-4409/8/10/1199/s1</uri>, Figure S1: Comparison of scn1LabAUG morphant and scn1Labs552/s552 mutant morphology and locomotor activity, Figure S2: Neuronal activity of scn1Lab model.</p>
<supplementary-material content-type="local-data" id="cells-08-01199-s001">
<media xlink:href="cells-08-01199-s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</app>
</app-group>
<notes>
<title>Author Contributions</title>
<p>N.S.-Y. and A.B., conceived and planned the experiments. A.B., performed the analysis, and designed the figures. R.H.-A., and J.S., contributed to the analysis of the results. C.Y., was involved in the planning and the reviewing of the manuscript. N.S.-Y., supervised the findings of this work, wrote and refined the article.</p>
</notes>
<notes>
<title>Funding</title>
<p>This work was supported by Institut National de la Santé et la Recherche Médicale (INSERM), the National Center for Scientific Research (CNRS), the French National Research Agency (ANR-16-CE18-0010), and Fondation NRJ (Institut de France) to NSY. Funding sources had no involvement in study design, collection, analysis or interpretation of data, or decision to publish.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-cells-08-01199">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dravet</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Dravet syndrome history</article-title>
<source/>Dev. Med. Child Neurol.
          <year>2011</year>
<volume>53</volume>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.2011.03964.x</pub-id>
<pub-id pub-id-type="pmid">21504424</pub-id>
</element-citation>
</ref>
<ref id="B2-cells-08-01199">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nolan</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Camfield</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Camfield</surname>
<given-names>P.R.</given-names>
</name>
</person-group>
<article-title>Coping with Dravet syndrome: Parental experiences with a catastrophic epilepsy</article-title>
<source/>Dev. Med. Child Neurol.
          <year>2006</year>
<volume>48</volume>
<fpage>761</fpage>
<lpage>765</lpage>
<pub-id pub-id-type="doi">10.1017/S0012162206001629</pub-id>
<pub-id pub-id-type="pmid">16904024</pub-id>
</element-citation>
</ref>
<ref id="B3-cells-08-01199">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohno</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Scn1a missense mutation causes limbic hyperexcitability and vulnerability to experimental febrile seizures</article-title>
<source/>Neurobiol. Dis.
          <year>2011</year>
<volume>41</volume>
<fpage>261</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2010.09.013</pub-id>
<pub-id pub-id-type="pmid">20875856</pub-id>
</element-citation>
</ref>
<ref id="B4-cells-08-01199">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obata</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Synaptic inhibition and γ-aminobutyric acid in the mammalian central nervous system</article-title>
<source/>Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci.
          <year>2013</year>
<volume>89</volume>
<fpage>139</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.2183/pjab.89.139</pub-id>
<pub-id pub-id-type="pmid">23574805</pub-id>
</element-citation>
</ref>
<ref id="B5-cells-08-01199">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ablain</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zon</surname>
<given-names>L.I.</given-names>
</name>
</person-group>
<article-title>Of fish and men: Using zebrafish to fight human diseases</article-title>
<source/>Trends Cell Biol.
          <year>2013</year>
<volume>23</volume>
<fpage>584</fpage>
<lpage>586</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2013.09.009</pub-id>
<pub-id pub-id-type="pmid">24275383</pub-id>
</element-citation>
</ref>
<ref id="B6-cells-08-01199">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grone</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Baraban</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Animal models in epilepsy research: Legacies and new directions</article-title>
<source/>Nat. Neurosci.
          <year>2015</year>
<volume>18</volume>
<fpage>339</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3934</pub-id>
<pub-id pub-id-type="pmid">25710835</pub-id>
</element-citation>
</ref>
<ref id="B7-cells-08-01199">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sourbron</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Partoens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Scheldeman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lagae</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Witte</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Drug repurposing for Dravet syndrome in <italic>scn1Lab <sup>−/−</sup></italic> mutant zebrafish</article-title>
<source/>Epilepsia
          <year>2019</year>
<volume>60</volume>
<fpage>e8</fpage>
<lpage>e13</lpage>
<pub-id pub-id-type="doi">10.1111/epi.14647</pub-id>
<pub-id pub-id-type="pmid">30663052</pub-id>
</element-citation>
</ref>
<ref id="B8-cells-08-01199">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baraban</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Dinday</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Hortopan</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment</article-title>
<source/>Nat. Commun.
          <year>2013</year>
<volume>4</volume>
<fpage>2410</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms3410</pub-id>
<pub-id pub-id-type="pmid">24002024</pub-id>
</element-citation>
</ref>
<ref id="B9-cells-08-01199">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinday</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Baraban</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Large-Scale Phenotype-Based Antiepileptic Drug Screening in a Zebrafish Model of Dravet Syndrome</article-title>
<source/>eNeuro
          <year>2015</year>
<volume>2</volume>
<pub-id pub-id-type="doi">10.1523/ENEURO.0068-15.2015</pub-id>
</element-citation>
</ref>
<ref id="B10-cells-08-01199">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<elocation-id>e0125898</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0125898</pub-id>
<pub-id pub-id-type="pmid">25965391</pub-id>
</element-citation>
</ref>
<ref id="B11-cells-08-01199">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grone</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Baraban</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Behavioral Comorbidities and Drug Treatments in a Zebrafish <italic>scn1lab</italic> Model of Dravet Syndrome</article-title>
<source/>eNeuro.
          <year>2017</year>
<pub-id pub-id-type="doi">10.1523/ENEURO.0066-17.2017</pub-id>
<pub-id pub-id-type="pmid">28812061</pub-id>
</element-citation>
</ref>
<ref id="B12-cells-08-01199">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hamling</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Knupp</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Baraban</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome</article-title>
<source/>Brain
          <year>2017</year>
<volume>140</volume>
<fpage>669</fpage>
<lpage>683</lpage>
<pub-id pub-id-type="doi">10.1093/brain/aww342</pub-id>
<pub-id pub-id-type="pmid">28073790</pub-id>
</element-citation>
</ref>
<ref id="B13-cells-08-01199">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Rowley</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fulton</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dinday</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Baraban</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Altered Glycolysis and Mitochondrial Respiration in a Zebrafish Model of Dravet Syndrome</article-title>
<source/>eNeuro
          <year>2016</year>
<volume>3</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1523/ENEURO.0008-16.2016</pub-id>
</element-citation>
</ref>
<ref id="B14-cells-08-01199">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Baraban</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Network Properties Revealed during Multi-Scale Calcium Imaging of Seizure Activity in Zebrafish</article-title>
<source/>eNeuro
          <year>2019</year>
<volume>6</volume>
<pub-id pub-id-type="doi">10.1523/ENEURO.0041-19.2019</pub-id>
<pub-id pub-id-type="pmid">30895220</pub-id>
</element-citation>
</ref>
<ref id="B15-cells-08-01199">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sourbron</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model</article-title>
<source/>ACS Chem. Neurosci.
          <year>2016</year>
<volume>7</volume>
<fpage>588</fpage>
<lpage>598</lpage>
<pub-id pub-id-type="doi">10.1021/acschemneuro.5b00342</pub-id>
<pub-id pub-id-type="pmid">26822114</pub-id>
</element-citation>
</ref>
<ref id="B16-cells-08-01199">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akerboom</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Optimization of a GCaMP calcium indicator for neural activity imaging</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<fpage>13819</fpage>
<lpage>13840</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2601-12.2012</pub-id>
<pub-id pub-id-type="pmid">23035093</pub-id>
</element-citation>
</ref>
<ref id="B17-cells-08-01199">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turrigiano</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>S.B.</given-names>
</name>
</person-group>
<article-title>Homeostatic plasticity in the developing nervous system</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2004</year>
<volume>5</volume>
<fpage>97</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1038/nrn1327</pub-id>
<pub-id pub-id-type="pmid">14735113</pub-id>
</element-citation>
</ref>
<ref id="B18-cells-08-01199">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kantamneni</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Cross-talk and regulation between glutamate and GABAB receptors</article-title>
<source/>Front. Cell. Neurosci.
          <year>2015</year>
<volume>9</volume>
<fpage>135</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00135</pub-id>
<pub-id pub-id-type="pmid">25914625</pub-id>
</element-citation>
</ref>
<ref id="B19-cells-08-01199">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stief</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zuschratter</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hartmann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Draguhn</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Enhanced synaptic excitation-inhibition ratio in hippocampal interneurons of rats with temporal lobe epilepsy</article-title>
<source/>Eur. J. Neurosci.
          <year>2007</year>
<volume>25</volume>
<fpage>519</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.05296.x</pub-id>
<pub-id pub-id-type="pmid">17284194</pub-id>
</element-citation>
</ref>
<ref id="B20-cells-08-01199">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eichler</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Glycinergic tonic inhibition of hippocampal neurons with depolarizing GABAergic transmission elicits histopathological signs of temporal lobe epilepsy</article-title>
<source/>J. Cell. Mol. Med.
          <year>2008</year>
<volume>12</volume>
<fpage>2848</fpage>
<lpage>2866</lpage>
<pub-id pub-id-type="doi">10.1111/j.1582-4934.2008.00357.x</pub-id>
<pub-id pub-id-type="pmid">19210758</pub-id>
</element-citation>
</ref>
<ref id="B21-cells-08-01199">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swaminathan</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Non-canonical mTOR-Independent Role of DEPDC5 in Regulating GABAergic Network Development</article-title>
<source/>Curr. Biol.
          <year>2018</year>
<volume>28</volume>
<fpage>1924</fpage>
<lpage>1937</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2018.04.061</pub-id>
<pub-id pub-id-type="pmid">29861134</pub-id>
</element-citation>
</ref>
<ref id="B22-cells-08-01199">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samarut</surname>
<given-names>É.</given-names>
</name>
</person-group>
<article-title>γ-Aminobutyric acid receptor alpha 1 subunit loss of function causes genetic generalized epilepsy by impairing inhibitory network neurodevelopment</article-title>
<source/>Epilepsia
          <year>2018</year>
<volume>59</volume>
<fpage>2061</fpage>
<lpage>2074</lpage>
<pub-id pub-id-type="doi">10.1111/epi.14576</pub-id>
<pub-id pub-id-type="pmid">30324621</pub-id>
</element-citation>
</ref>
<ref id="B23-cells-08-01199">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dallman</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Spatial patterning of excitatory and inhibitory neuropil territories during spinal circuit development</article-title>
<source/>J. Comp. Neurol.
          <year>2017</year>
<volume>525</volume>
<fpage>1649</fpage>
<lpage>1667</lpage>
<pub-id pub-id-type="doi">10.1002/cne.24152</pub-id>
<pub-id pub-id-type="pmid">27997694</pub-id>
</element-citation>
</ref>
<ref id="B24-cells-08-01199">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Higashijima</surname>
<given-names>S.I.</given-names>
</name>
</person-group>
<article-title>Generation of Multiple Classes of V0 Neurons in Zebrafish Spinal Cord: Progenitor Heterogeneity and Temporal Control of Neuronal Diversity</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<fpage>1771</fpage>
<lpage>1783</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5500-11.2012</pub-id>
<pub-id pub-id-type="pmid">22302816</pub-id>
</element-citation>
</ref>
<ref id="B25-cells-08-01199">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hirata</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Suster</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Higashijima</surname>
<given-names>S.I.</given-names>
</name>
</person-group>
<article-title>Transgenic tools to characterize neuronal properties of discrete populations of zebrafish neurons</article-title>
<source/>Development
          <year>2013</year>
<volume>140</volume>
<fpage>3927</fpage>
<lpage>3931</lpage>
<pub-id pub-id-type="doi">10.1242/dev.099531</pub-id>
<pub-id pub-id-type="pmid">23946442</pub-id>
</element-citation>
</ref>
<ref id="B26-cells-08-01199">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Alterations of apoptosis and autophagy in developing brain of rats with epilepsy: Changes in LC3, P62, Beclin-1 and Bcl-2 levels</article-title>
<source/>Neurosci. Res.
          <year>2018</year>
<volume>130</volume>
<fpage>47</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1016/j.neures.2017.08.004</pub-id>
<pub-id pub-id-type="pmid">28807642</pub-id>
</element-citation>
</ref>
<ref id="B27-cells-08-01199">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotloski</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lauersdorf</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sutula</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Repeated brief seizures induce progressive hippocampal neuron loss and memory deficits</article-title>
<source/>Prog. Brain Res.
          <year>2002</year>
<volume>2</volume>
<fpage>95</fpage>
<lpage>110</lpage>
</element-citation>
</ref>
<ref id="B28-cells-08-01199">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henshall</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Modulators of neuronal cell death in epilepsy</article-title>
<source/>Curr. Opin. Pharmacol.
          <year>2008</year>
<volume>8</volume>
<fpage>75</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/j.coph.2007.07.005</pub-id>
<pub-id pub-id-type="pmid">17827063</pub-id>
</element-citation>
</ref>
<ref id="B29-cells-08-01199">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Callus</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Vaux</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>Caspase inhibitors: Viral, cellular and chemical</article-title>
<source/>Cell Death Differ.
          <year>2007</year>
<volume>14</volume>
<fpage>73</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1038/sj.cdd.4402034</pub-id>
<pub-id pub-id-type="pmid">16946729</pub-id>
</element-citation>
</ref>
<ref id="B30-cells-08-01199">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in the zebrafish embryo: Local circulation failure in the dorsal midbrain is associated with increased apoptosis</article-title>
<source/>Toxicol. Sci.
          <year>2002</year>
<volume>69</volume>
<fpage>191</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/69.1.191</pub-id>
<pub-id pub-id-type="pmid">12215674</pub-id>
</element-citation>
</ref>
<ref id="B31-cells-08-01199">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregory-Evans</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Moosajee</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gregory-Evans</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Gene-specific differential response to anti-apoptotic therapies in zebrafish models of ocular Coloboma</article-title>
<source/>Mol. Vis.
          <year>2011</year>
<volume>17</volume>
<fpage>1473</fpage>
<lpage>1484</lpage>
<pub-id pub-id-type="pmid">21677791</pub-id>
</element-citation>
</ref>
<ref id="B32-cells-08-01199">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Holder</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Cell turnover in neuromasts of zebrafish larvae</article-title>
<source/>Hear. Res.
          <year>2000</year>
<volume>143</volume>
<fpage>171</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-5955(00)00039-3</pub-id>
<pub-id pub-id-type="pmid">10771194</pub-id>
</element-citation>
</ref>
<ref id="B33-cells-08-01199">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Gal</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>A case of SUDEP in a patient with Dravet syndrome with SCN1A mutation</article-title>
<source/>Epilepsia
          <year>2010</year>
<volume>51</volume>
<fpage>1915</fpage>
<lpage>1918</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02691.x</pub-id>
<pub-id pub-id-type="pmid">20738378</pub-id>
</element-citation>
</ref>
<ref id="B34-cells-08-01199">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Molecular organization of the postsynaptic specialization</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2001</year>
<volume>98</volume>
<fpage>7058</fpage>
<lpage>7061</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.111146298</pub-id>
<pub-id pub-id-type="pmid">11416187</pub-id>
</element-citation>
</ref>
<ref id="B35-cells-08-01199">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzarelli</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Tuning GABAergic Inhibition: Gephyrin Molecular Organization and Functions</article-title>
<source/>Neuroscience
          <year>2019</year>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2019.07.036</pub-id>
<pub-id pub-id-type="pmid">31356900</pub-id>
</element-citation>
</ref>
<ref id="B36-cells-08-01199">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cline</surname>
<given-names>H.T.</given-names>
</name>
</person-group>
<article-title>Excitatory synaptic dysfunction cell-autonomously decreases inhibitory inputs and disrupts structural and functional plasticity</article-title>
<source/>Nat. Commun.
          <year>2018</year>
<volume>9</volume>
<fpage>2893</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-05125-4</pub-id>
<pub-id pub-id-type="pmid">30042473</pub-id>
</element-citation>
</ref>
<ref id="B37-cells-08-01199">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonansco</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fuenzalida</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Plasticity of Hippocampal Excitatory-Inhibitory Balance: Missing the Synaptic Control in the Epileptic Brain</article-title>
<source/>Neural Plast.
          <year>2016</year>
<volume>2016</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1155/2016/8607038</pub-id>
</element-citation>
</ref>
<ref id="B38-cells-08-01199">
<label>38.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>DeLorey</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Delgado-Escueta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>R.W.</given-names>
</name>
</person-group>
<article-title>GABRB3, Epilepsy, and Neurodevelopment</article-title>
<source/>Jasper’s Basic Mechanisms of the Epilepsies [Internet]
          <edition>4th ed.</edition>
<person-group person-group-type="editor">
<name>
<surname>Noebels</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Avoli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rogawski</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<publisher-name>National Center for Biotechnology Information</publisher-name>
<publisher-loc>Bethesda, MD, USA</publisher-loc>
<year>2012</year>
</element-citation>
</ref>
<ref id="B39-cells-08-01199">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bozzi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Casarosa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Caleo</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Epilepsy as a Neurodevelopmental Disorder</article-title>
<source/>Front. Psychiatry
          <year>2012</year>
<volume>3</volume>
<fpage>19</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2012.00019</pub-id>
<pub-id pub-id-type="pmid">22457654</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="cells-08-01199-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Correlation between LFP and calcium activity in <italic>scn1Lab</italic> model. (<bold>A</bold>) Schematic of the experimental setup to simultaneously record local field potential and calcium activity of a larval zebrafish brain. (<bold>B</bold>,<bold>C</bold>) Calcium images showing respectively the baseline activity (<bold>B</bold>) and the seizure activity (<bold>C</bold>). The fluorescence intensity is color-coded as shown in the color bar below the images. (<bold>D</bold>,<bold>E</bold>) Representative 20 min calcium recording of immobilized and paralyzed 4 dpf control (<bold>D</bold>) (<italic>N</italic> = 9) and <italic>scn1Lab</italic> (<bold>E</bold>) (<italic>N</italic> = 9) larvae. Each calcium event is shown with an orange arrowhead. (<bold>F</bold>) Number of events, calcium increases greater that 0.04 Δ<italic>F/F</italic><sub>0</sub> amplitude, during 1 h recording. (<bold>G</bold>) Representative LFP, recorded in the left neuropil of the optic tectum, and calcium traces, from the optic tectum, of a paralyzed and immobilized 4 dpf <italic>scn1Lab</italic> larva. (<bold>H</bold>) Correlation between LFP and calcium events duration (<italic>n</italic> = 46). <italic>N</italic> = number of larvae and <italic>n</italic> = number of events. Error bars on all graphs represent standard error of the mean (SEM). ***, <italic>p</italic> &lt; 0.001. <italic>p</italic>-value was determined using Student’s unpaired <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="cells-08-01199-g001"></graphic>
</fig>
<fig id="cells-08-01199-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Defects of excitatory/inhibitory balance in the Scn1Lab-depleted larvae. (<bold>A</bold>,<bold>B</bold>) 20 µm coronal sections of 5 dpf control (<bold>A</bold>) (<italic>N</italic> = 5, <italic>n</italic> = 15) and <italic>scn1Lab</italic> (<bold>B</bold>) (<italic>N</italic> = 5, <italic>n</italic> = 15) larvae stained with PSD-95, an excitatory post-synaptic scaffolding protein. (<bold>D</bold>,<bold>E</bold>) 20 µm coronal sections of 5 dpf control (<bold>D</bold>) (<italic>N</italic> = 5, <italic>n</italic> = 20) and <italic>scn1Lab</italic> (<bold>E</bold>) (<italic>N</italic> = 5, <italic>n</italic> = 19) larvae stained with gephyrin, an inhibitory post-synaptic scaffolding protein. Images were acquired with a SP8 Leica laser scanning confocal microscope equipped with a 40x/oil 1.3 objective. Scale bar 5 µm. (<bold>C</bold>,<bold>F</bold>) Quantification of PSD-95 (<bold>C</bold>) and gephyrin (<bold>F</bold>) puncta density. (<bold>G</bold>) PSD-95/gephyrin puncta density ratio. <italic>N</italic> = number of larvae and <italic>n</italic> = number of sections. Error bars on all graphs represent standard error mean (SEM). **, <italic>p</italic> &lt; 0.01. <italic>p</italic>-values were determined using the Mann-Whitney test.</p>
</caption>
<graphic xlink:href="cells-08-01199-g002"></graphic>
</fig>
<fig id="cells-08-01199-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Evolution of the excitatory-inhibitory neuronal population in the <italic>scn1Lab</italic> model. (<bold>A<sub>1-3</sub></bold>,<bold>B<sub>1-3</sub></bold>) Dorsal view of 3 dpf Tg[Gad1b:GFP; Vglut2a:DsRed] control (<bold>A<sub>1-3</sub></bold>) (<italic>N</italic> = 8) and <italic>scn1Lab</italic> (<bold>B<sub>1-3</sub></bold>) (<italic>N</italic> = 8) living larvae. (<bold>A<sub>1</sub></bold>,<bold>B<sub>1</sub></bold>) Inhibitory neurons (Gad1b:GFP) in 3 dpf control (<bold>A<sub>1</sub></bold>) and <italic>scn1Lab</italic> (<bold>B<sub>1</sub></bold>) larvae. (<bold>A<sub>2</sub></bold>,<bold>B<sub>2</sub></bold>) Excitatory neurons (Vglut2a:DsRed) in 3 dpf control (<bold>A<sub>2</sub></bold>) and <italic>scn1Lab</italic> (<bold>B<sub>2</sub></bold>) larvae. (<bold>A<sub>3</sub></bold>,<bold>B<sub>3</sub></bold>) Merged image of 3 dpf control (<bold>A<sub>3</sub></bold>) and <italic>scn1Lab</italic> (<bold>B<sub>3</sub></bold>) larvae. (<bold>C</bold>) Dorsal view schematic of a 4 dpf larva. The red rectangle shows the region of interest. (<bold>E<sub>1-3</sub></bold>,<bold>F<sub>1-3</sub></bold>) Dorsal view of 4 dpf Tg[Gad1b:GFP; Vglut2a:DsRed] control (<bold>E<sub>1-3</sub></bold>) (<italic>N</italic> = 8) and <italic>scn1Lab</italic> (<bold>F<sub>1-3</sub></bold>) (<italic>N</italic> = 8) living larvae. (<bold>E<sub>1</sub></bold>,<bold>F<sub>1</sub></bold>) Inhibitory neurons (Gad1b:GFP) in 4 dpf control (<bold>E<sub>1</sub></bold>) and <italic>scn1Lab</italic> (<bold>F<sub>1</sub></bold>) larvae. (<bold>E<sub>2</sub></bold>,<bold>F<sub>2</sub></bold>) Excitatory neurons (Vglut2a:DsRed) in 4 dpf control (<bold>E<sub>2</sub></bold>) and <italic>scn1Lab</italic> (<bold>F<sub>2</sub></bold>) larvae. (<bold>E<sub>3</sub></bold>,<bold>F<sub>3</sub></bold>) Merged image of 4 dpf control (<bold>E<sub>3</sub></bold>) and <italic>scn1Lab</italic> (<bold>F<sub>3</sub></bold>) larvae. (<bold>H<sub>1-3</sub></bold>,<bold>I<sub>1-3</sub></bold>) Dorsal view of 5 dpf Tg[Gad1b:GFP; Vglut2a:DsRed] control (<bold>H<sub>1-3</sub></bold>) (<italic>N</italic> = 8) and <italic>scn1Lab</italic> (<bold>I<sub>1-3</sub></bold>) (<italic>N</italic> = 8) living larvae. (<bold>H<sub>1</sub></bold>,<bold>I<sub>1</sub></bold>) Inhibitory neurons (Gad1b:GFP) in 5 dpf control (<bold>H<sub>1</sub></bold>) and <italic>scn1Lab</italic> (<bold>I<sub>1</sub></bold>) larvae. (<bold>H<sub>2</sub></bold>,<bold>I<sub>2</sub></bold>) Excitatory neurons (Vglut2a:DsRed) in 5 dpf control (<bold>H<sub>2</sub></bold>) and <italic>scn1Lab</italic> (<bold>I<sub>2</sub></bold>) larvae. (<bold>H<sub>3</sub></bold>,<bold>I<sub>3</sub></bold>) Merged image of 5 dpf control (<bold>H<sub>3</sub></bold>) and <italic>scn1Lab</italic> (<bold>I<sub>3</sub></bold>) larvae. (<bold>D</bold>,<bold>G</bold>,<bold>J</bold>) Number of neurons in control and <italic>scn1Lab</italic> larvae at 3 dpf (<bold>D</bold>), 4 dpf (<bold>G</bold>) and 5 dpf (<bold>J</bold>). (<bold>K</bold>,<bold>L</bold>,<bold>M</bold>) Number of inhibitory and excitatory neurons in control and <italic>scn1Lab</italic> larvae at 3 dpf (<bold>K</bold>), 4 dpf (<bold>L</bold>) and 5 dpf (<bold>M</bold>). All images are representative 20 µm stacks acquired using LSM 880 Zeiss laser scanning confocal microscope equipped with a WPApo 20x/1.0 objective. Scale bar 40 µm. <italic>N</italic> = number of embryos. Error bars on all graphs represent standard error mean (SEM). * <italic>p</italic> &lt; 0.05; ** <italic>p</italic> &lt; 0.01; ***,<italic>p</italic> &lt; 0.001 indicate a statistically significant difference between control and <italic>scn1Lab</italic> larvae. Statistically significant difference between inhibitory and excitatory neuronal population is indicated as $$, <italic>p</italic> &lt; 0.01; $$$, <italic>p</italic> &lt; 0.001. <italic>p</italic>-values were determined using Student’s unpaired <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="cells-08-01199-g003"></graphic>
</fig>
<fig id="cells-08-01199-f004" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>Increased neuronal death in Scn1Lab-depleted larvae. (<bold>A</bold>,<bold>B</bold>) Dorsal view of 4 dpf living control (<bold>A</bold>) (<italic>N</italic> = 15) and <italic>scn1Lab</italic> (<bold>B</bold>) (<italic>N</italic> = 15) larvae stained with acridine orange; 100 µm stack. Scale bar 40 µm. (<bold>C</bold>) Dorsal view schematic of 4 dpf larva. The red rectangle shows the region of interest for global cell death quantification. (<bold>D</bold>) Number of acridine orange-positive cells in 4 dpf brain. (<bold>E</bold>,<bold>F</bold>) Dorsal view of 4 dpf control (<bold>E</bold>) (<italic>N</italic> = 24) and <italic>scn1Lab</italic> (<bold>F</bold>) (<italic>N</italic> = 22) brain stained with activated caspase-3 antibody; 100 µm stack. Scale bar 40 µm. (<bold>G</bold>) Number of activated caspase-3-positive cells in 4 dpf brain. (<bold>H-I</bold>) Dorsal view of 4 dpf Z-VAD-treated control (<bold>H</bold>) (<italic>N</italic> = 18) and <italic>scn1Lab</italic> (<bold>I</bold>) (<italic>N</italic> = 16) larvae stained with acridine orange; 100 µm stack. Scale bar 40 µm. (<bold>J</bold>) Number of acridine orange-positive cells in 4 dpf brain. (<bold>K</bold>) Dorsal view schematic of 4 dpf larva. The red rectangle shows the region of interest for activated caspase-3 signal colocalization with inhibitory and excitatory neurons quantification. (<bold>L</bold>) Number of inhibitory (Gad1b:GFP) and excitatory (Vglut2a:DsRed) neurons also showing activated caspase-3 labelling in control and <italic>scn1Lab</italic> larvae. (<bold>M<sub>1-4</sub>, N<sub>1-4</sub></bold>) Dorsal view of 4 dpf Tg[Gad1b:GFP; Vglut2a:DsRed] control (<bold>M<sub>1-4</sub></bold>) (<italic>N</italic> = 14) and <italic>scn1Lab</italic> (<bold>N<sub>1-4</sub></bold>) (<italic>N</italic> = 14) brain stained with activated caspase-3 antibody; representative 15 µm stack. Scale bar 10 µm. (<bold>M<sub>1</sub>,N<sub>1</sub></bold>) Inhibitory neurons (Gad1b:GFP) in control (<bold>M<sub>1</sub></bold>) and <italic>scn1Lab</italic> (<bold>N<sub>1</sub></bold>) larvae. (<bold>M<sub>2</sub>,N<sub>2</sub></bold>) Excitatory neurons (Vglut2a:DsRed) in control (<bold>M<sub>2</sub></bold>) and <italic>scn1Lab</italic> (<bold>N<sub>2</sub></bold>) larvae. (<bold>M<sub>3</sub>,N<sub>3</sub></bold>) Activated caspase-3 staining in control (<bold>M<sub>3</sub></bold>) and <italic>scn1Lab</italic> (<bold>N<sub>3</sub></bold>) larvae. (<bold>M<sub>4</sub>,N<sub>4</sub></bold>) Merged images of control (<bold>M<sub>4</sub></bold>) and <italic>scn1Lab</italic> (<bold>N<sub>4</sub></bold>) larvae. Excitatory neurons with activated caspase-3 expression are shown by arrowheads, while inhibitory neurons with activated caspase-3 expression are shown by arrows. Images were all acquired with an SP8 Leica laser scanning confocal microscope equipped with 40x/water 1.1 objective. <italic>N</italic> = number of embryos. Error bars on all graphs represent standard error mean (SEM). *, <italic>p</italic> &lt; 0.05; ***, <italic>p</italic> &lt; 0.001 indicate a statistically significant difference between control and scn1Lab larvae. A statistically significant difference between inhibitory and excitatory neuronal population is indicated as $$$, <italic>p</italic> &lt; 0.001. <italic>p</italic>-values were determined using Student’s unpaired <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="cells-08-01199-g004"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>